Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/19/2003EP0833644B1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
03/19/2003EP0804467B1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
03/19/2003EP0796106B1 Protracted glp-1 compositions
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0733645B1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome
03/19/2003EP0722463B1 Methods and composition for the modulation of host immune response to allergens
03/19/2003EP0702572B1 Biological adhesive composition and method of promoting adhesion between tissue surfaces
03/19/2003EP0702559B1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003EP0670904B1 Vector for the expression of therapy-relevant genes
03/19/2003EP0667902B1 Cdr grafted humanised chimeric t-cell antibodies
03/19/2003EP0657520B1 Antioxidant
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same
03/19/2003CN1404486A Purified LH (Luteinizing hormone)
03/19/2003CN1404485A Process of purification of hCG and recombinant hCG purified by that method
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404401A G-CSF conjugates
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404397A Endoparasiticidal agent composition
03/19/2003CN1404396A Polypeptoid pulmonary surfactants
03/19/2003CN1403584A Casein enzymolyzing process with compound proteinase to prepare casein phosphopeptide and the use of casein phosphopeptide
03/19/2003CN1403573A Method of raising the yield of insect baculovirus with insect juvenoid
03/19/2003CN1403569A In vivo established strain of genetic recombined inteferon and its use
03/19/2003CN1403484A Prepn and application of transmembrane staphylococcus aureus toxin A fusion protein
03/19/2003CN1403483A Human erythropoietin Fc fusion protein with raised bioactivity
03/19/2003CN1403474A Short peptide and medicine with short peptide as active component
03/19/2003CN1403156A Application of human urokininogenase in preparing medicine for preventing and treating cerebral infraction
03/19/2003CN1403155A Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
03/19/2003CN1403154A Application of Hepcidin in pharmacy
03/19/2003CN1403153A Water dispersive nano level bone morphogenetic protein injection prepn and its prepn process
03/19/2003CN1403152A Composition for keeping skin's moisture and delaying skin's senility and its prepn
03/19/2003CN1103221C Medicine for treating HIV infections
03/18/2003US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates
03/18/2003US6534645 Compositions and methods enabling a totally internally controlled amplification reaction
03/18/2003US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534640 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
03/18/2003US6534635 Tissue inhibitors of metalloproteinase (TIMP); electron-accepting group causes it to lose its ability to bind to metalloproteinase; carbamylation; inhibition of metastasis of cancer or vascularization
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534631 Of given amino acid sequence; use in diagnosing and treating diseases related to them
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534629 Isolated protein inhibiting blood coagulation factor X; use in drugs
03/18/2003US6534626 Chemokine variants
03/18/2003US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors
03/18/2003US6534523 Racemates, diastereoisomers and optical isomers of a compound of formula (I): synthesis, compositions and methods for the treatment of hepatitis C virus (HCV) infection and intermediates
03/18/2003US6534503 Melanocortin receptor-3 ligands to treat sexual dysfunction
03/18/2003US6534495 Anticoagulants that prevent thrombin-related diseases.
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein.
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534479 Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534475 Methods and compositions for treating ocular neovascularization with TIMP-3, TIMP-3 inducers, and TIMP-3 mimetics are disclosed. tissue inhibitors of metalloproteinases (TIMPs) over the past several years
03/18/2003US6534310 Suppression of proteolytic activity by dysfunctional protease formation
03/18/2003US6534302 22438, 23553, 25278, and 26212 novel human sulfatases
03/18/2003US6534301 Nucleotide sequences coding enzymatic polypeptide for use in treating cell proliferation and differentiation defects
03/18/2003US6534300 Methods for producing highly phosphorylated lysosomal hydrolases
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534290 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
03/18/2003US6534289 Recombinant nucleic acid encoding receptor having amino acid sequences of extracellular domain of G-protein coupled calcium receptor, seven-transmembrane and intracellular cytoplasmic tail domains of group I metabotropic glutamate receptor
03/18/2003US6534287 Isolated and purified nucleic acid molecule comprising nucleotides which code for specified amino acid sequence
03/18/2003US6534283 Method for treatment and prevention of physiological shock
03/18/2003US6534276 Methods for detecting human tissue factor inhibitor
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534259 Regressive behavioral disorder diagnosis
03/18/2003US6534088 Fibrate-statin combinations with reduced fed-fasted effects
03/18/2003US6534063 Utilizing fecal chymotrypsin level as prognosticative of success of secretin, other neuropeptides, peptides or digestive enzymes
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534060 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
03/18/2003US6534057 Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/18/2003US6534050 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003US6534035 Methods of inhibiting clot formation
03/18/2003US6533819 Injectable implants for tissue augmentation and restoration
03/18/2003CA2263181C Anti-chlamydial methods and materials
03/18/2003CA2220347C Compositions and methods for detecting and treating acquired immunodeficiency syndrome
03/18/2003CA2176840C Combination of an antimicrobial compound with a glycerol monoalkylether
03/18/2003CA2165694C Erythropoietin analogs
03/18/2003CA2139652C Thrombin-inhibitors
03/18/2003CA2126356C Human serum-albumin, preparation and use thereof
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2092519C Synthetic polypeptides as inhibitors of hiv-1
03/18/2003CA2085134C Gdf-1
03/18/2003CA2040412C Brain derived neurotrophic factor
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
03/14/2003WO2003025166A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/14/2003CA2460377A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021266A1 The great gene and protein
1 ... 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 ... 3163